Pharmaceutical patents and the right to health – Portugal and Brazil (Vol.13, N.1)

Autor: Ruben Bahamonde Delgado

Publikováno v: Janus.net, Vol 13, Iss 1, Pp 171-189 (2022)

The defence of the patent system's legitimacy, namely in the pharmaceutical field, is consolidated, although it is not exempt from criticism. Historically, when the patent law, a legal monopoly right, is confronted with the right of access to health,

Externí odkaz: https://doaj.org/article/ad535c74ae0a4d519443c05a380748b4

Brexit – The Consequences for Pharmaceutical Patents and Supplementary Protection Certificates

Autor: Harry Melville O'Brien, Anna Louise Hatt, James Alexander Stones

Publikováno v: British Journal of Pharmacy, Vol 6, Iss 1 (2021)

Now that the UK has left the EU, and the transition period following this departure is over, we have a clearer view on the implications of Brexit on intellectual property rights and the consequences for UK based pharmaceutical companies. Although lit

Externí odkaz: https://doaj.org/article/5fa01b120e6f4845a79a8f35152aaf34

The Quest for Secondary Pharmaceuticals: Drug Repurposing/Chiral-Switches Combination Strategy

Autor: Ilaria D’Acquarica, Israel Agranat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8eaafac995fa2c672bcf54433d07b4cc
https://hdl.handle.net/11573/1670036

From Necessity to Flexibility: A Reflection on the Negotiations for a TRIPS Waiver for Covid-19 Vaccines and Treatments

Autor: Bryan Mercurio, Pratyush Nath Upreti

Publikováno v: Mercurio, B & Upreti, P N 2022, ' From Necessity to Flexibility: A Reflection on the Negotiations for a TRIPS Waiver for Covid-19 Vaccines and Treatments ', World Trade Review, vol. 21, no. 5, pp. 633-649 . https://doi.org/10.1017/S1474745622000283, https://doi.org/10.1017/S1474745622000283

This article critically examines the proposed waiver of intellectual property (IP) rights for COVID-19 vaccines under the World Trade Organization Agreement's Trade-Related Aspects of Intellectual Property Rights (TRIPS), which was initiated in Octob

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb8a8793e3d8c2052c97c66ecaaa2f4f
https://pure.qub.ac.uk/en/publications/5bff4573-8459-46c0-aaf2-2ad6d9a7b452

Pharmaceutical patents: General characteristics and current issues in the international context

Autor: Lasić Ines

Publikováno v: Pravni Zapisi, Vol 5, Iss 1, Pp 176-196 (2014)

A patent can be defined as an exclusive right that is granted to the patent owner, which allows him to prevent others from making, selling, importing or using the invention, without license or authorization for a period of 20 years. This right is giv

Externí odkaz: https://doaj.org/article/93437efaf8a142f69145cf820bb58d62